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Abstract
Background: Cryptogenic stroke frequently occurs in younger patients and has a high risk of recurrence.
Consequently, secondary prevention is often suboptimal as there is no known risk factor to target. This case
demonstrates an unexpected finding of middle cerebral artery infarction and extensive malignant transformation
in a 16-year-old boy more than a day post-admission. The lack of a proven culprit lesion makes this case even
more intriguing and subsequently raises questions of cryptogenic mechanisms in the context of unrelated trauma.
Case presentation: A 16-year-old white boy had been stabbed in his chest but had a Glasgow Coma Scale score
of 15. Over a day later he developed sudden signs and symptoms consistent with a neurological event of unknown
etiology. Computed tomography demonstrated significant cerebral edema but was equivocal in its list of differentials.
A computed tomography scan of his chest demonstrated no cardiac wall or vascular injury and he was transferred
to our neurosurgical unit for intracranial pressure monitoring. A computed tomography angiogram revealed an
unexpected finding of malignant middle cerebral artery infarction. Failure to medically manage his intracranial
pressure resulted in a decompressive craniectomy less than 12-hours postictus. Despite extensive diagnostic
investigations no culprit lesion was identified and no patent foramen ovale found. Since discharge he has
returned to full functional status. He was the youngest patient (mean age of 43 years) out of a 10-year institutional
retrospective on decompressive craniectomies for malignant middle cerebral artery infarction (n = 40) and had the
singularly best Glasgow Outcome Scale score of 5.
Conclusions: This case highlights the preponderance of cryptogenic stroke in younger patients and its etiological
elusiveness. It further demonstrates that age is predictive in terms of survival and functional outcome in the context
of malignant middle cerebral artery infarction.
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Background
In the UK, stroke is the fourth leading cause of death
and the largest cause of complex disability [1, 2]. The
incidence of malignant middle cerebral artery infarction
(mMCAI) is 1% of all strokes (approximately 1520
patients per annum) [2] and carries an 80% 30-day
mortality if neurosurgical intervention does not occur
[1]. With infarction of greater than 50% of middle cere-
bral artery (MCA) territory, a significant mass effect
and concomitant herniation of brain tissue may occur
resulting in rapid demise. Recent randomized con-
trolled trials (RCTs) and subsequent meta-analysis
make it clear that surgical intervention and subsequent
survival and functional outcome are inversely propor-
tional to age [1]. Furthermore, cryptogenic stroke
frequently occurs in younger patients and due to it
being notoriously difficult to identify a culprit lesion
secondary prevention is often suboptimal [1, 2].
Case presentation
A 16-year-old white boy presented due to being stabbed
in his chest. He had a blood alcohol level of 145 mg/dL
and was hemodynamically compromised but had no head
trauma: his Glasgow Coma Scale (GCS) score was 15. A
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plain chest X-ray (CXR) confirmed a left-sided pneumo-
thorax. Insertion of a 32 Fr chest drain expelled 100 ml of
fresh blood. He was admitted under our general surgical
team and was making a good recovery.
On the second post-admission day he experienced sud-
den onset left leg hemiplegia: Medical Research Council
(MRC) Grade 1. He was Babinski positive and had hemi-
neglect. He became incontinent of urine, his GCS dropped
to 11 (E3 V3 M4), and his pupils were reactive at size 4.
An electrocardiogram (ECG) showed ST-segment eleva-
tion but his troponin I was not elevated.
A computed tomography (CT) scan of his head at
0918 hours (Fig. 1) demonstrated a right-sided 8 × 7 ×
7 cm mass causing left ventricular dilation, 10 mm mid-
line shift, right hemispheric sulcal effacement, and early
uncal herniation. This was unexpected due to absence of
vessel hyperdensity and no head injury.
A CT scan of his chest demonstrated a potential
non-penetrating pericardial injury and pericardial and
pleural effusions but no obvious ventricular wall injury.
A transthoracic echocardiogram (TTE) revealed no
ventricular wall motion derangement. He was intubated
for transfer to our neurosurgical intensive care unit
(ICU) that morning.
On admission to our neurosurgical ICU he had no eye
movements but was localizing to pain. He was not coa-
gulopathic and his mean arterial blood pressure (MAP)
was 95 mmHg, an intracranial pressure (ICP) bolt
inserted in the ICU recorded an ICP of 38 mmHg, and
his cerebral perfusion pressure (CPP) was 57 mmHg.
A repeat CT scan of his head at 1645 hours (Fig. 2)
demonstrated a 6 mm midline shift, complete obliteration
of his basal cisterns, and generalized sulcal effacement
(100 ml 20% mannitol was given). A thoracic CT angio-
gram was conducted to exclude occult pathology but this
was normal. An unexpected finding on his cranial CT
angiogram was mMCAI. It was decided that an aggressive
surgical approach was warranted, that is, a right-sided de-
compressive craniectomy, and this was immediately carried
out (Fig. 3). The ICP bolt was removed intraoperatively.
On the second postoperative day he was localizing to
pain but remained hemiplegic. A repeat TTE demon-
strated good systolic function and a small pericardial
effusion but no tamponade, thrombus, or septal defects.
He was extubated on the fifth postoperative day and
discharged from ICU.
He made excellent progress over a month and had no
focal neurological deficits. Aspirin at 150 mg daily was
commenced but not warfarin (as no thrombus was
proven). A laboratory examination revealed no lupus anti-
coagulant and cardiolipin antibodies, no family history of
clotting disorders, and a normal cerebrospinal fluid (CSF)
protein. A repeat TTE demonstrated no regional wall ab-
normality (and no septal defects), a bubble test at 4-weeks
postictus was normal, and CT angiograms of his aorta and
aortic arch were once again both normal. No magnetic
resonance imaging (MRI) was conducted based on advice
from the stroke physicians because the embolic lesion was
Fig. 1 Computed tomography (axial) demonstrating a right-sided
lesion of indeterminate nature causing mass effect and significant
midline shift
Fig. 2 Computed tomography (axial) demonstrating a large middle
cerebral artery infarct and concomitant perilesional edema
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clearly visible on CT. At 3-months postictus he was fully
independent having a Glasgow Outcome Scale (GOS)
score of 5. Three titanium cranioplasties were required
over a 3-year period for infective complications. He now
drives a car and is in full-time employment.
Discussion
Cryptogenic stroke accounts for 23 to 45% of all strokes
and frequently occurs in younger patients [1–5]. It has a
high risk of recurrence and subsequent incidence of
transient ischemic attacks (TIAs). As no clear under-
lying etiology exists adherence to treatment is often
suboptimal (as there is nothing to target). The use of
advanced diagnostic techniques includes: long-term
monitoring to capture paroxysmal atrial fibrillation (AF);
high-resolution MRI to detect plaque, dissection, or
vasculitis; and CT angiography to evaluate aortocardiac
embolism to identify culprit lesions to target [3, 4].
Due to the cause remaining elusive, his cryptogenic
stroke was probably transitory being triggered by his ori-
ginal trauma. This is in keeping with cryptogenic stroke
as diagnostic modalities may remain normal even if
delayed until after the acute illness has passed [3, 4].
Our patient did not undergo 24-hour Holter monitoring
as AF detection rates using this modality are inferior to
serial ECGs (these did not reveal AF) and implantable
long-term cardiac monitoring was not indicated [4, 5].
Further imaging using TTE and CT angiography
excluded cardiac lesions, paradoxical and aortogenic
embolism, atrial septal aneurysm, aortic atheroma, and
arterial dissection. A patent foramen ovale (PFO) was
ruled out on multiple TTEs [4, 5].
Other transitory causes include vasospasm, hypercoag-
ulable states, for example sickle cell disease [3, 4], and
migraine-induced stroke [3, 4]. All, except vasospasm,
were excluded as he did not undergo digital subtraction
angiography (DSA). Consequently, it might remain
cryptogenic as TTE is considered the gold standard in-
vestigation in the evaluation of cryptogenic stroke (and
he had three).
A coagulopathy was excluded and three TTEs were
undertaken: the use of transesophageal echocardiography
(TEE) is equivocal [4–7]. Although clinical (for example
diabetic), genetic (for example clotting disorders), and
electrophysiological (for example premature atrial
complexes, left atrial dilatation, and reduced left ven-
tricular ejection fraction) causes were excluded some
hematological biomarkers, for example pro-brain natri-
uretic peptide, were not investigated [7]. According to re-
cent research, these might be predictive for incident AF in
cryptogenic stroke [4]. Karaaslan et al. [8] demonstrated
that an etiology can challengingly remain elusive.
Karaaslan et al. [8] described a case of cryptogenic
stroke in a 19-year-old woman undergoing elective
laparotomy for resection of a pancreatic pseudopapillary
tumor. There had been significant intraoperative blood
loss requiring an ICU admission postoperatively. Once
extubated 12 hours later she was unable to speak and
had a left facial droop. A CT scan of her head demon-
strated bilateral thalamic infarcts (subsequently confirmed
on MRI) and treatment included anticoagulation. Subse-
quent investigations including TTEs, TEEs, and genetic,
collagen, vascular, and coagulation profile studies failed to
identify a potential source of embolic stroke, for example
a PFO did not exist, and failed to demonstrate any physio-
logical abnormalities that might have generated a hyperco-
agulable or coagulable state. She made a full recovery
except for minimal memory deficits [7, 8].
Potential sources of our patient’s culprit lesion include
a paradoxical embolism because a probe-patent PFO
may allow right to left shunting only under specific con-
ditions and toxins as he was found in an isolated street.
Conclusions
This case demonstrates a fact that mMCAI can present
in a myriad of ways and is potentially devastating. Al-
though he made a full recovery he remains at high risk
of future strokes due to the cryptogenic nature of his
original presentation despite being thoroughly investigated
(including genetic studies) [3, 5]. Clearly, more research
is needed into this particular type of stroke to identify a
potential source for culprit lesions as cryptogenic stroke
has a predilection for otherwise young healthy patients
Fig. 3 Computed tomography (axial) showing a large right-sided
craniectomy and expansion of brain parenchyma away from
the midline
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rendering them to a lifetime of future strokes and
serious morbidity.
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